With a market cap of $145.7 billion, Pfizer Inc. (PFE) is a global, research-driven biopharmaceutical company, specializing ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...

Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily comply ...